Generic-Drug Exclusivity 'Squatting' Draws Bipartisan Heat
The Trump administration on Tuesday found common ground with congressional Democrats in backing legislation to prevent generic-drug makers with exclusivity rights from blocking other generics for prolonged periods of time....To view the full article, register now.
Already a subscriber? Click here to view full article